| Title |
Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy
|
|---|---|
| Published in |
Cancer Immunology Research, August 2021
|
| DOI | 10.1158/2326-6066.cir-21-0147 |
| Pubmed ID | |
| Authors |
Lauren Dennison, Amanda Ruggieri, Aditya Mohan, James Leatherman, Kayla Cruz, Skylar Woolman, Nilofer Azad, Gregory B. Lesinski, Elizabeth M. Jaffee, Mark Yarchoan |
X Demographics
The data shown below were collected from the profiles of 34 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 18 | 53% |
| Brazil | 1 | 3% |
| Italy | 1 | 3% |
| United Kingdom | 1 | 3% |
| Australia | 1 | 3% |
| Georgia | 1 | 3% |
| France | 1 | 3% |
| Unknown | 10 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 50% |
| Scientists | 10 | 29% |
| Practitioners (doctors, other healthcare professionals) | 5 | 15% |
| Science communicators (journalists, bloggers, editors) | 2 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 20 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 3 | 15% |
| Other | 2 | 10% |
| Student > Ph. D. Student | 2 | 10% |
| Student > Bachelor | 1 | 5% |
| Unspecified | 1 | 5% |
| Other | 2 | 10% |
| Unknown | 9 | 45% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 3 | 15% |
| Medicine and Dentistry | 3 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 10% |
| Immunology and Microbiology | 2 | 10% |
| Unspecified | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 9 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2022.
All research outputs
#1,494,720
of 23,482,849 outputs
Outputs from Cancer Immunology Research
#139
of 1,442 outputs
Outputs of similar age
#36,454
of 431,754 outputs
Outputs of similar age from Cancer Immunology Research
#6
of 37 outputs
Altmetric has tracked 23,482,849 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,442 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,754 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.